Chemistry
R
100%
Aldehyde
36%
Kd
27%
Schiff Base
27%
Protein
18%
Hydroxyl Group
18%
Modification
18%
Cytotoxic
18%
Ethane
9%
Condensation
9%
Phosphorus-31 Magnetic Resonance Spectroscopy
9%
Mass Spectrometry
9%
Cisplatin
9%
Elemental Analysis
9%
1H NMR Spectroscopy
9%
Cyclization Reaction
9%
Thioredoxin
9%
Nucleophilic Addition
9%
X-Ray Crystallography
9%
Antineoplastic Agent
9%
Fluorescence Quenching
9%
Structure
9%
Time
9%
Group
9%
Biochemistry, Genetics and Molecular Biology
Binding Affinity
27%
Binding Protein
18%
Antineoplastic Activity
18%
Human Serum Albumin
18%
Position
18%
Cancer Cell
9%
Cytotoxicity
9%
Mass Spectrometry
9%
Docking (Molecular)
9%
Nuclear Magnetic Resonance Spectroscopy
9%
Cisplatin
9%
Lysozyme
9%
X-Ray Crystallography
9%
Cyclization
9%
Addition Reaction
9%
Quenching (Fluorescence)
9%
Nucleophilicity
9%
31P NMR Spectroscopy
9%
Time
9%
Experiment
9%
Thioredoxin Reductase
9%
Pharmacology, Toxicology and Pharmaceutical Science
Aldehyde
36%
Schiff Base
27%
Hydroxyl Group
18%
Human Serum Albumin
18%
Gold Complex
18%
Protein Binding
18%
Anticarcinogen
9%
Enzyme
9%
Element
9%
Cisplatin
9%
Phosphorus 31
9%
Reduced Nicotinamide Adenine Dinucleotide Dehydrogenase (Ubiquinone)
9%
Cytochrome C Oxidase
9%
Ovary Carcinoma
9%
Non Small Cell Lung Cancer
9%
Thioredoxin Reductase
9%
X-Ray
9%